Daniel Mario Lima

Daniel Mario Lima

Auto-generated profile, based on publicly available information

Daniel Mario Lima

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in IEEE Transactions on Visualization and Computer Graphics
Verified
Journal Article
Closed access
CLClaudio D. G. Linhares
Claudio D. G. Linhares
DLDaniel M. Lima
Daniel M. Lima
JPJean R. Ponciano
Jean R. Ponciano
MOMauro M. Olivatto
Mauro M. Olivatto
MGMarco Antonio Gutierrez
Marco Antonio Gutierrez
ATAgma Juci Machado Traina
Agma Juci Machado Traina
Physicians work at a very tight schedule and need decision-making support tools to help on improving and doing their work in a timely and dependable manner. Examining piles of sheets with test results and using systems with little visualization support to provide diagnostics is daunting, but that is still the usual way for the physicians' daily procedure, especially in developing countries. Electronic Health Records systems have been designed to keep the patients' history and reduce the time spent analyzing the patient's data. However, better tools to support decision-making are still needed. In this paper, we propose ClinicalPath, a visualization tool for users to track a patient's clinical path through a series of tests and data, which can aid in treatments and diagnoses. Our proposal is focused on patient's data analysis, presenting the test results and clinical history longitudinally. Both the visualization design and the system functionality were developed in close collaboration with experts in the medical domain to ensure a right fit of the technical solutions and the real needs of the professionals. We validated the proposed visualization based on case studies and user assessments through tasks based on the physician's daily activities. Our results show that our proposed system improves the physicians' experience in decision-making tasks, made with more confidence and better usage of the physicians' time, allowing them to take other needed care for the patients.

20 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCCarlos Roberto Ribeiro Carvalho
Carlos Roberto Ribeiro Carvalho
CLCelina Almeida Lamas
Celina Almeida Lamas
RCRodrigo Caruso Chate
Rodrigo Caruso Chate
JSJoão Marcos Salge
João Marcos Salge
MSMarcio Valente Yamada Sawamura
Marcio Valente Yamada Sawamura
HGHCFMUSP Covid-19 Study Group
HCFMUSP Covid-19 Study Group
Background: Coronavirus disease (COVID-19) survivors exhibit multisystemic alterations after hospitalization. Little is known about long-term imaging and pulmonary function of hospitalized patients intensive care unit (ICU) who survive COVID-19. We aimed to investigate long-term consequences of COVID-19 on the respiratory system of patients discharged from hospital ICU and identify risk factors associated with chest computed tomography (CT) lesion severity. Methods: A prospective cohort study of COVID-19 patients admitted to a tertiary hospital ICU in Brazil (March-August/2020), and followed-up six-twelve months after hospital admission. Initial assessment included: modified Medical Research Council dyspnea scale, SpO2 evaluation, forced vital capacity, and chest X-Ray. Patients with alterations in at least one of these examinations were eligible for CT and pulmonary function tests (PFTs) approximately 16 months after hospital admission. Primary outcome: CT lesion severity (fibrotic-like or non-fibrotic-like). Baseline clinical variables were used to build a machine learning model (ML) to predict the severity of CT lesion. Results: In total, 326 patients (72%) were eligible for CT and PFTs. COVID-19 CT lesions were identified in 81.8% of patients, and half of them showed mild restrictive lung impairment and impaired lung diffusion capacity. Patients with COVID-19 CT findings were stratified into two categories of lesion severity: non-fibrotic-like (50.8%-ground-glass opacities/reticulations) and fibrotic-like (49.2%-traction bronchiectasis/architectural distortion). No association between CT feature severity and altered lung diffusion or functional restrictive/obstructive patterns was found. The ML detected that male sex, ICU and invasive mechanic ventilation (IMV) period, tracheostomy and vasoactive drug need during hospitalization were predictors of CT lesion severity(sensitivity,0.78±0.02;specificity,0.79±0.01;F1-score,0.78±0.02;positive predictive rate,0.78±0.02; accuracy,0.78±0.02; and area under the curve,0.83±0.01). Conclusion: ICU hospitalization due to COVID-19 led to respiratory system alterations six-twelve months after hospital admission. Male sex and critical disease acute phase, characterized by a longer ICU and IMV period, and need for tracheostomy and vasoactive drugs, were risk factors for severe CT lesions six-twelve months after hospital admission.

9 June 2023 in IEEE Access
Verified
Journal Article
Open access
TCThiago Bulhões Da Silva Costa
Thiago Bulhões Da Silva Costa
FDFelipe Meneguitti Dias
Felipe Meneguitti Dias
DCDiego Armando Cardona Cardenas
Diego Armando Cardona Cardenas
MTMarcelo Arruda Fiuza De Toledo
Marcelo Arruda Fiuza De Toledo
DLDaniel Mário De Lima
Daniel Mário De Lima
MGMarco Antonio Gutierrez
Marco Antonio Gutierrez
Cardiovascular diseases are the leading causes of death, and blood pressure (BP) monitoring is essential for prevention, diagnosis, assessment, and treatment. Photoplethysmography (PPG) is a low-cost opto-electronic technique for BP measurement that allows the acquisition of a modulated light signal highly correlated with BP. There are several reports of methods to estimate BP from PPG with impressive results; in this study, we demonstrate that the previous results are excessively optimistic because of their train/test split configuration. To manage this limitation, we considered intra- and inter-subject data arrangements and demonstrated how they affect the results of feature-based BP estimation algorithms (i.e., XGBoost, LightGBM, and CatBoost) and signal-based algorithms (i.e., Residual U-Net, ResNet-18, and ResNet-LSTM). Inter-subject configuration performance is inferior to intra-subject configuration performance, regardless of the model. We also showed that, using only demographic attributes (i.e., age, sex, weight, and subject index number), a regression model achieved results comparable to those obtained in an intra-subject scenario.Although limited to a public clinical database, our findings suggest that algorithms that use an intra-subject setting without a calibration strategy may be learning to identify patients and not predict BP.

1 January 2019
Verified
Book Chapter
Open access
PDF file
LMLima Daniel M.
Lima Daniel M.
RFRodrigues-Jr Jose F.
Rodrigues-Jr Jose F.
TJTraina Agma J.M.
Traina Agma J.M.
PAPires Fabio A.
Pires Fabio A.
GAGutierrez Marco A.
Gutierrez Marco A.
This paper presents the extract-transform-and-load (ETL) process from the Electronic Patient Records (ePR) at the Heart Institute (InCor) to the OMOP Common Data Model (CDM) format. We describe the initial database characterization, relational source mappings, selection filters, data transformations and patient de-identification using the open-source OHDSI tools and SQL scripts. We evaluate the resulting InCor-CDM database by recreating the same patient cohort from a previous reference study (over the original data source) and comparing the cohorts' descriptive statistics and inclusion reports. The results exhibit that up to 91% of the reference patients were retrieved by our method from the ePR through InCor-CDM, with AUC=0.938. The results indicate that the method that we employed was able to produce a new database that was both consistent with the original data and in accordance to the OMOP CDM standard.

30 April 2021 in SN Computer Science
Verified
Journal Article
Closed access
PDF file
DLDaniel M. Lima
Daniel M. Lima
JJJose F Rodrigues Jr
Jose F Rodrigues Jr
BBBruno Brandoli
Bruno Brandoli
Lorraine GoeuriotLorraine Goeuriot
Lorraine Goeuriot
SASihem Amer-Yahia
Sihem Amer-Yahia

12 June 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
CCCarlos Roberto Ribeiro Carvalho
Carlos Roberto Ribeiro Carvalho
RCRodrigo Caruso Chate
Rodrigo Caruso Chate
MSMarcio Valente Yamada Sawamura
Marcio Valente Yamada Sawamura
MGMichelle Louvaes Garcia
Michelle Louvaes Garcia
CLCelina Almeida Lamas
Celina Almeida Lamas
MGMarco Antonio Gutierrez
Marco Antonio Gutierrez
Objective: This study aimed to propose a simple, accessible and low-cost predictive clinical model to detect lung lesions due to COVID-19 infection. Design: This prospective cohort study included COVID-19 survivors hospitalised between 30 March 2020 and 31 August 2020 followed-up 6 months after hospital discharge. The pulmonary function was assessed using the modified Medical Research Council (mMRC) dyspnoea scale, oximetry (SpO2), spirometry (forced vital capacity (FVC)) and chest X-ray (CXR) during an in-person consultation. Patients with abnormalities in at least one of these parameters underwent chest CT. mMRC scale, SpO2, FVC and CXR findings were used to build a machine learning model for lung lesion detection on CT. Setting: A tertiary hospital in Sao Paulo, Brazil. Participants: 749 eligible RT-PCR-confirmed SARS-CoV-2-infected patients aged ≥18 years. Primary outcome measure: A predictive clinical model for lung lesion detection on chest CT. Results: There were 470 patients (63%) that had at least one sign of pulmonary involvement and were eligible for CT. Almost half of them (48%) had significant pulmonary abnormalities, including ground-glass opacities, parenchymal bands, reticulation, traction bronchiectasis and architectural distortion. The machine learning model, including the results of 257 patients with complete data on mMRC, SpO2, FVC, CXR and CT, accurately detected pulmonary lesions by the joint data of CXR, mMRC scale, SpO2 and FVC (sensitivity, 0.85±0.08; specificity, 0.70±0.06; F1-score, 0.79±0.06 and area under the curve, 0.80±0.07). Conclusion: A predictive clinical model based on CXR, mMRC, oximetry and spirometry data can accurately screen patients with lung lesions after SARS-CoV-2 infection. Given that these examinations are highly accessible and low cost, this protocol can be automated and implemented in different countries for early detection of COVID-19 sequelae.